2008
Haematopoetic stem cell transplantation in children in eastern Europenean countries 185 - 2004: development, recent activity and role of the EBMT/ESH Outreach Programe
WACHOWIAK, J.; M. LABOPIN; M. MIANO; A. CHYBICKA; J. STARÝ et. al.Basic information
Original name
Haematopoetic stem cell transplantation in children in eastern Europenean countries 185 - 2004: development, recent activity and role of the EBMT/ESH Outreach Programe
Name in Czech
Transplantace kostní dřeně u dětí v letech 1985 2004 v centrech evropských zemí.
Authors
WACHOWIAK, J. (826 United Kingdom of Great Britain and Northern Ireland); M. LABOPIN (826 United Kingdom of Great Britain and Northern Ireland); M. MIANO (826 United Kingdom of Great Britain and Northern Ireland); A. CHYBICKA (203 Czech Republic); J. STARÝ (203 Czech Republic); Jaroslav ŠTĚRBA (203 Czech Republic, guarantor); T. MASSZI (826 United Kingdom of Great Britain and Northern Ireland); B. LABAR (826 United Kingdom of Great Britain and Northern Ireland); A. MASCHAN (826 United Kingdom of Great Britain and Northern Ireland); J.R. KOWALCZYK (826 United Kingdom of Great Britain and Northern Ireland); A. LANGE (826 United Kingdom of Great Britain and Northern Ireland); J. HOLOWIECKI (826 United Kingdom of Great Britain and Northern Ireland); N. KALMAN (826 United Kingdom of Great Britain and Northern Ireland); B.V. AFANASSIEV (826 United Kingdom of Great Britain and Northern Ireland) and G. DINI (826 United Kingdom of Great Britain and Northern Ireland)
Edition
Bone Marrow Transplant, GB, London, NATURE PUBLISHING GROUP, 2008, 0268-3369
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
is not subject to a state or trade secret
Impact factor
Impact factor: 3.400
RIV identification code
RIV/00216224:14110/08:00028312
Organization unit
Faculty of Medicine
UT WoS
000256660100025
Keywords in English
HSCT Children Central and eastern European Countires
Tags
International impact, Reviewed
Changed: 26/6/2009 12:43, prof. MUDr. Jaroslav Štěrba, Ph.D.
In the original language
The paediatric population of 19 eastern European countries amounts to approximately 80 million children. Between 1985 and 2004, the number of centres performing haematopoietic stem cell transplantation (HSCT) in children increased from 1 in 1985 to 24 in 2004 and the yearly number of paediatric HSCTs rose from 1 in 1985 to 291 in 2004. Altogether, 2342 transplants were reported to the EBMT Registry during this time (Poland 953, Czech Republic 501, Hungary 269, Russia 217, Croatia 129, Slovakia 71, Bulgaria 45, Serbia and Montenegro 36, Slovenia 35, Belarus 33, Estonia 26, Lithuania 19 and Romania 8). Out of the 2342 transplants, 1487 (63.5%) transplants were performed in paediatric centres, 453 (19.3%) in centres for adults and 402 (17.2%) in combined centres. The number of children who underwent autologous HSCT (auto-HSCT) was 1053 (45%), whereas 1289 (55%) underwent allogeneic HSCT (allo-HSCT). Peripheral blood (PB) was the source of HSC in 751 (71.3%) out of 1053 auto-transplants, BM in 246 (23.4%) and PB+BM in 52 (4.9%) (missing data in 4, that is, 0.4%). Among the 1289 allo-transplants, BM was the source of HSC in 827 (64.3%), PB in 416 (32.3%), CB in 23 (1.8%) and BM+PB in 14 (1.1%) (missing data in 9, that is, 0.7%). Among them, 728 (57.4%) obtained HSC from MSD, 322 (25.4%) from UD, 195 (15.4%) from MMFD, 14 (1.1%) from CB family donor and 9 (0.7%) from CB unrelated donor (missing data in 21, that is, 1.6%). The number of children who underwent allo-HSCT for malignant diseases was 945 (73.4%), including ALL 376 (29.2%), AML 234 (18.2%), CML 177 (13.8%), MDS 97 (7.5%), NHL 35 (2.7%) and other malignancy 31 (2.4%), while 339 (26.9%) for non-malignant disorders, including SAA 202 (15.7%), immunodeficiencies 61 (4.7%), inborn errors of metabolism 40 (3.1%), Fanconi anaemia 19 (1.5%) and others 17 (1.3%). Out of 1053 recipients of auto-HSCT, 168 (16%) were transplanted for neuroblastoma, 129 (12.2%) for NHL, 124 (11.7%) for AML, 114 (10.8%) for ALL, 109 (10.4%) for Hodgkin's disease, 62 (5.9%) for Ewing's sarcoma, 16 (1.5%) for CNS tumour, 15 (1.4%) for Wilms tumour and 316 (30%) for other tumours. In 2001, the EBMT in collaboration with the European School of Haematology (ESH) developed the Outreach Programme, that is a programme supporting emerging HSCT projects and transplant centres in countries with limited resources and/or experience.
In Czech
Populace dětí v 19 zemích východní Evropy je cca 80 milionů. Práce popisuje celkem 2342 provedených transplantací kostní dřeně u dětí v letech 1985 2004 v celkem 24 centrech 19 zemí.
Links
1A8709, research and development project |
|